Experienced private equity and operations executive focused on growth-stage healthcare and tech investments, Joyce Provost combines investor and operator perspectives to source and scale portfolio companies. She has led deal execution, value-creation programs and board oversight across commercial growth, M&A and performance improvement. Background spans operational leadership in clinical services and strategic investing; typically works with middle-market buyouts and growth equity with a focus on revenue growth and margin expansion.
Experienced private equity and operations executive focused on growth-stage healthcare and tech investments, Joyce Provost combines investor and operator perspectives to source and scale portfolio companies. She has led deal execution, value-creation programs and board oversight across commercial growth, M&A and performance improvement. Background spans operational leadership in clinical services and strategic investing; typically works with middle-market buyouts and growth equity with a focus on revenue growth and margin expansion.
Combines operator-driven private equity discipline with growth-stage focus, prioritizing healthcare and tech businesses where revenue acceleration and margin expansion are achievable through commercial transformation and operational improvement. Emphasizes rigorous due diligence, active board-level engagement, and hands-on value-creation plans—commercial go-to-market, M&A integration, and performance improvement—favoring middle-market buyouts and growth equity with a multi-year horizon and targeted, risk-adjusted returns.
Combines operator-driven private equity discipline with growth-stage focus, prioritizing healthcare and tech businesses where revenue acceleration and margin expansion are achievable through commercial transformation and operational improvement. Emphasizes rigorous due diligence, active board-level engagement, and hands-on value-creation plans—commercial go-to-market, M&A integration, and performance improvement—favoring middle-market buyouts and growth equity with a multi-year horizon and targeted, risk-adjusted returns.
| Trades 1263 | Longs Won 845/1263 66% | Profit Factor 8.4 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $557,686.63 |
| Average Win $128,917.36 | Best Trade (Jul 15) $11.05M | Sharpe Ratio -96.46 |
| Average Loss -$31,039.67 | Worst Trade (Jul 10) -$630,507.77 | Z-Score 1.98 (95.25%) |
| Commissions $0 | Avg. Trade Length 1y 3m 1w 1d | Expectancy $75,953.29 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,130 | 7,317 | 6,504 | 5,691 | 4,878 | 4,065 | 3,252 | 2,439 | 1,626 | 813 |